OTC Healthcare in Brazil
Euromonitor International's OTC Healthcare in Brazil market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Get immediate access to strategic market analysis when you buy reports online
Tables: 105 | Publication date: Aug 2007
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Adult mouthcare; Allergy care; Analgesics; Calming and sleeping products; Child-specific OTC healthcare; Cough; cold and allergy (hay fever) remedies; Digestive remedies; Ear care; Emergency contraception; Eye care; Medicated skin care; NRT Smoking cessation aids; OTC obesity; OTC statins; OTC triptans; Vitamins and dietary supplements; Wound treatments
Executive summary
OTC Sales Advance in 2006
After a weak performance in 2003 due to devaluation of the Real and economic instability, the OTC healthcare market recovered the following year by posting double-digit growth. 2005, however, was marked by political problems due to corruption scandals, thus hindering sales that year. With an improvement in Brazilians' purchasing power and a more stable economy, OTC healthcare recorded current value growth of 9% in 2006. NRT smoking cessation aids saw the highest growth thanks to an increasing number of smokers trying to quit the habit with the help of NRT patches and gum.
OTC Advertising Strictly Regulated
Brazil is well known for its price controls and strict regulations on the advertising of medicines, which is only allowed for OTC products. Although manufacturers and trade associations were able to free some OTC products – mostly in analgesics, cough, cold and allergy remedies and vitamins – from price control, there is still a long way to go before agreement can be reached between ANVISA (National Sanitary Surveillance Agency) and manufacturers with regard to advertising. Further changes are expected in 2007 with regard to Resolution No 138 which covers OTC advertising regulations. However, there are no expectations that these changes will rejuvenate the market in the short term.
Direct Selling on the Rise
Aventis Pharma continued to lead OTC healthcare primarily thanks to its popular analgesic brands Dorflex and Novalgina. Nevertheless, Herbalife and Tahitian Noni – both direct selling companies – increased their sales significantly over the review period thanks to their multilevel marketing strategies and high-quality products which attracted thousands of direct selling consultants. In a short period, Herbalife and Tahitian Noni have become two of the key players in vitamins and dietary supplements.
Sales of OTC Medicines in Grocery Stores
With Brazilian regulations prohibiting sales of OTC medicines in grocery stores and other food shops, sales continue to be dominated by drugstores/parapharmacies. To become a viable option for consumers purchasing medicines, the largest supermarket/hypermarket chains invested in opening licensed drugstores within their establishments, following the same legal obligations as other drugstores. Distribuição and Wal-Mart already have more than 100 drugstores located in their supermarkets/hypermarkets.
Informality and High Taxes Are Still Far from a Solution
The informal market, which consists of a variety of companies and products which in some way or other do not fully satisfy all their legal obligations, illegal sales of stolen medication and elevated taxes are the main issues that concern all OTC manufacturers and are likely to continue to hinder further growth of the market. Despite efforts from manufacturers and trade associations in negotiating measures to stimulate the market, this problem is likely to persist over the long term.
Table of contents
OTC HEALTHCARE IN BRAZIL : MARKET INSIGHT
EXECUTIVE SUMMARY
OTC Sales Advance in 2006
OTC Advertising Strictly Regulated
Direct Selling on the Rise
Sales of OTC Medicines in Grocery Stores
Informality and High Taxes Are Still Far from a Solution
KEY TRENDS AND DEVELOPMENTS
Investment in More Appealing Packaging a Way to Attract Consumers
Price Control Drives Debate
Strict Advertising Regulations
Informality Distorts Competition and Slows Down Development
No Preservatives in Some Products
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services 2001-2006
Table 2 Life Expectancy at Birth 2001-2006
MARKET DATA
Table 3 Sales of OTC Healthcare by Sector: Value 2001-2006
Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2001-2006
Table 5 OTC Healthcare Company Shares by Retail Value 2002-2006
Table 6 OTC Healthcare Brand Shares by Retail Value 2003-2006
Table 7 Penetration of Private Label by Sector 2002-2006
Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis 2001/2006
Table 9 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2006
Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2006-2011
Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2006-2011
APPENDIX
OTC Registration and Classification
Vitamins & Dietary Supplements Registration and Classification
Generics
Consumer Expenditure on Health Goods and Medical Services
Table 12 Consumer Expenditure on Health Goods and Medical Services 2001-2006
DEFINITIONS
Sources
Summary 1 Research Sources
LOCAL COMPANY PROFILES - BRAZIL
ACHê LABORATóRIOS FARMACêUTICOS SA - OTC HEALTHCARE - BRAZIL
STRATEGIC DIRECTION
KEY FACTS
Summary 2 Achê Laboratórios Farmacêuticos SA: Key Facts
Summary 3 Achê Laboratórios Farmacêuticos SA: Operational Indicators 2003-2005
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 4 Achê Laboratórios Farmacêuticos SA: Competitive Position 2006
AVENTIS PHARMA LTDA - OTC HEALTHCARE - BRAZIL
STRATEGIC DIRECTION
KEY FACTS
Summary 5 Aventis Pharma Ltda: Key Facts
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 6 Aventis Pharma Ltda: Competitive Position 2006
BAYER SA - OTC HEALTHCARE - BRAZIL
STRATEGIC DIRECTION
KEY FACTS
Summary 7 Bayer SA: Key Facts
Summary 8 Bayer SA: Operational Indicators 2003-2005
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 9 Bayer SA: Competitive Position 2006
BRISTOL-MYERS SQUIBB BRASIL SA - OTC HEALTHCARE - BRAZIL
STRATEGIC DIRECTION
KEY FACTS
Summary 10 Bristol-Myers Squibb Brasil SA: Key Facts
Summary 11 Bristol-Myers Squibb Brasil SA: Operational Indicators 2004-2005
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 12 Bristol-Myers Squibb Brasil SA: Competitive Position 2006
CADBURY ADAMS BRASIL INDúSTRIA E COMéRCIO DE PRODUTOS ALIMENTíCIOS LTDA - OTC HEALTHCARE - BRAZIL
STRATEGIC DIRECTION
KEY FACTS
Summary 13 Cadbury Adams Indústria e Comércio de Produtos Alimentícios Ltda: Key Facts
Summary 14 Cadbury Adams Indústria e Comércio de Produtos Alimentícios Ltda: Operational Indicators 2003-2005
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 15 Cadbury Adams Indústria e Comércio de Produtos Alimentícios Ltda: Competitive Position 2006
EMS SA - OTC HEALTHCARE - BRAZIL
STRATEGIC DIRECTION
KEY FACTS
Summary 16 EMS SA: Key Facts
Summary 17 EMS SA: Operational Indicators 2003-2005
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 18 EMS SA: Competitive Position 2006
EUROFARMA LABORATóRIO LTDA - OTC HEALTHCARE - BRAZIL
STRATEGIC DIRECTION
KEY FACTS
Summary 19 Eurofarma Laboratório Ltda: Key Facts
Summary 20 Eurofarma Laboratório Ltda: Operational Indicators 2003-2005
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 21 Eurofarma Laboratório Ltda: Competitive Position 2006
HERBARIUM LABORATóRIO BOTâNICO LTDA - OTC HEALTHCARE - BRAZIL
STRATEGIC DIRECTION
KEY FACTS
Summary 22 Herbarium Laboratório Botânico Ltda: Key Facts
Summary 23 Herbarium Laboratório Botânico Ltda: Operational Indicators 2004-2005
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 24 Herbarium Laboratório Botânico Ltda: Competitive Position 2006
MEDLEY SA INDúSTRIA FARMACêUTICA - OTC HEALTHCARE - BRAZIL
STRATEGIC DIRECTION
KEY FACTS
Summary 25 Medley SA Indústria Farmacêutica: Key Facts
Summary 26 Medley SA Indústria Farmacêutica: Operational Indicators 2004-2005
COMPANY BACKGROUND
PRODUCTION
Summary 27 Medley SA Indústria Farmacêutica: Production Statistics 2006
COMPETITIVE POSITIONING
Summary 28 Medley SA Indústria Farmacêutica: Competitive Position 2006
ANALGESICS IN BRAZIL
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 13 Sales of Analgesics by Subsector: Value 2001-2006
Table 14 Sales of Analgesics by Subsector: % Value Growth 2001-2006
Table 15 Herbal vs Standard Topical Analgesics 2001/2006
Table 16 Analgesics Company Shares by Retail Value 2002-2006
Table 17 Analgesics Brand Shares by Retail Value 2003-2006
Table 18 Forecast Sales of Analgesics by Subsector: Value 2006-2011
Table 19 Forecast Sales of Analgesics by Subsector: % Value Growth 2006-2011
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN BRAZIL
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 20 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2001-2006
Table 21 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2001-2006
Table 22 Sales of Decongestants by Type: Value 2001-2006
Table 23 Sales of Decongestants by Type: % Value Growth 2001-2006
Table 24 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2001-2006
Table 25 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2001-2006
Table 26 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2001/2006
Table 27 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Retail Value 2002-2006
Table 28 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Retail Value 2003-2006
Table 29 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2006-2011
Table 30 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2006-2011
DIGESTIVE REMEDIES IN BRAZIL
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 31 Sales of Digestive Remedies by Subsector: Value 2001-2006
Table 32 Sales of Digestive Remedies by Subsector: % Value Growth 2001-2006
Table 33 Herbal vs Standard Digestive Remedies 2001/2006
Table 34 Digestive Remedies Company Shares by Retail Value 2002-2006
Table 35 Digestive Remedies Brand Shares by Retail Value 2003-2006
Table 36 Forecast Sales of Digestive Remedies by Subsector: Value 2006-2011
Table 37 Forecast Sales of Digestive Remedies by Subsector: % Value Growth 2006-2011
MEDICATED SKIN CARE IN BRAZIL
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 38 Sales of Medicated Skin Care by Subsector: Value 2001-2006
Table 39 Sales of Medicated Skin Care by Subsector: % Value Growth 2001-2006
Table 40 Herbal vs Standard Medicated Skin Care 2001/2006
Table 41 Medicated Skin Care Company Shares by Retail Value 2002-2006
Table 42 Medicated Skin Care Brand Shares by Retail Value 2003-2006
Table 43 Acne Treatments Brand Shares by Retail Value 2003-2006
Table 44 Hair Loss Treatments Brand Shares by Retail Value 2003-2006
Table 45 Forecast Sales of Medicated Skin Care by Subsector: Value 2006-2011
Table 46 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2006-2011
VITAMINS AND DIETARY SUPPLEMENTS IN BRAZIL
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 47 Sales of Vitamins and Dietary Supplements by Subsector: Value 2001-2006
Table 48 Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2001-2006
Table 49 Sales of Vitamins by Type: Value 2001-2006
Table 50 Sales of Vitamins by Type: % Value Growth 2001-2006
Table 51 Vitamins and Dietary Supplements Company Shares by Retail Value 2002-2006
Table 52 Vitamins and Dietary Supplements Brand Shares by Retail Value 2003-2006
Table 53 Vitamins Brand Shares by Retail Value 2003-2006
Table 54 Sales of Dietary Supplements by Type: Value 2001-2006
Table 55 Sales of Dietary Supplements by Type: % Value Growth 2001-2006
Table 56 Dietary Supplements Brand Shares by Retail Value 2003-2006
Table 57 Forecast Sales of Vitamins and Dietary Supplements by Subsector: Value 2006-2011
Table 58 Forecast Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2006-2011
NRT SMOKING CESSATION AIDS IN BRAZIL
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR INDICATORS
Table 59 Number of Smokers by Gender 2001-2006
SECTOR DATA
Table 60 Sales of Smoking Cessation Aids by Subsector: Value 2001-2006
Table 61 Sales of Smoking Cessation Aids by Subsector: % Value Growth 2001-2006
Table 62 Smoking Cessation Aids Company Shares by Retail Value 2002-2006
Table 63 Smoking Cessation Aids Brand Shares by Retail Value 2003-2006
Table 64 Forecast Sales of Smoking Cessation Aids by Subsector: Value 2006-2011
Table 65 Forecast Sales of Smoking Cessation Aids by Subsector: % Value Growth 2006-2011
EYE CARE IN BRAZIL
OVERVIEW
SECTOR DATA
Table 66 Sales of Eye Care by Subsector: Value 2001-2006
Table 67 Sales of Eye Care by Subsector: % Value Growth 2001-2006
Table 68 Eye Care Company Shares by Retail Value 2002-2006
Table 69 Eye Care Brand Shares by Retail Value 2003-2006
Table 70 Forecast Sales of Eye Care by Subsector: Value 2006-2011
Table 71 Forecast Sales of Eye Care by Subsector: % Value Growth 2006-2011
EAR CARE IN BRAZIL
OVERVIEW
ADULT MOUTHCARE IN BRAZIL
OVERVIEW
CALMING AND SLEEPING PRODUCTS IN BRAZIL
OVERVIEW
WOUND TREATMENTS IN BRAZIL
OVERVIEW
SECTOR DATA
Table 72 Sales of Wound Treatments by Subsector: Value 2001-2006
Table 73 Sales of Wound Treatments by Subsector: % Value Growth 2001-2006
Table 74 Wound Treatments Company Shares by Retail Value 2002-2006
Table 75 Wound Treatments Brand Shares by Retail Value 2003-2006
Table 76 Forecast Sales of Wound Treatments by Subsector: Value 2006-2011
Table 77 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2006-2011